Junshi Biology released news on March 4. On February 29, 2024 and March 1, 2024, the company received research from many institutions such as Minsheng Securities, received personnel, company's main management personnel, etc., and received location strategy meeting. Wait.
Research Main Contents
q 1: the company's overall operation and future plans in 2023? a: according to the company's 2023 annual performance bulletin, the company's annual operating income in 2023 is about 1.54 billion yuan, which is an increase compared with the annual operating income in 2022, mainly due to the increase in the sales income of three commercial drugs (tuoyi?, junmaikang?, mintewei?) compared with the same period last year. At the same time, in 2023, the company strengthened the control of various expenses, excellent...
Click to view the original PDF
List of recipients
| serial number | recipient | recipient type | |||
|---|---|---|---|---|---|
| 1 | Open source Securities | Securities Company | |||
| 2 | Hua An Securities | Cathay Pacific Fund | Fund | ||
| 4 | Huatai Asset Management | Asset Management Company | |||
| 5 | fund management company|||||
| 6 | Guoshou Asset | Insurance 7 | Capital | Asset Management Company | |
| 8 | Guojin Fund | ||||
| 9 | Soochow Asset Management | Asset Management Company | |||
| 10 | hanggui Investment|||||
| Data source: Choice data |
Note: Due to space constraints, only the top 10 institutions are shown.
Institutional Research Backtest
In addition to the same day, Junshi Biology has received 765 surveys from 595 institutions in the past year. The historical backtests are shown in the following table:
back-testing of institutional research in the past year
| announcement date | number of reception facilities | absolute rate of return (%) | excess rate of return (%) | |||||
|---|---|---|---|---|---|---|---|---|
| Next Day | 5th | 10th | Next Day | 5th | 10th | |||
| 2024-02-06 | 10 | 12.71 | 11.14 | 9.11 | 11.75 | 6.76 | 4.92 | 2023-12-29 | -1.39 | -5.09 | -9.13 | -0.08 | -0.86 | -4.75 |
| 289 | -2.90 | -3.97 | -8.15 | -2.86 | -5.29 | -8.42 | 2023-09-08 | 58 | 4.56 | 4.12 | 4.37 | 3.83 | 4.95 | 4.40 |
| 2023-09-01 | 124 | -0.08 | -5.69 | -1.81 | -1.59 | -4.33 | <0.37 | |
| 2023-07-31 | 28 | 0.32-6.61 | -3.61 | 0.73 | -6.00 | 0.34 | ||
| 2023-06-01 | 90 | 2.70 | td>-10.22-8.27 | -4.14 | -10.57 | -11.39 | ||
| 2023-04-28 | 139 | -1.10 | -3.64 | -1.69 | -1.13 | -2.84 | 0.02 | |
| Data Source: Choice Data |
Note: 1. The market adjustment model is selected for the calculation of excess return in this paper, with the CSI 300 index as the benchmark index, and the excess return = actual return-benchmark return; 2. "Nearly one year" means nearly one year as of the latest announcement date.
Market Agency Research
on March 4, hanzhong precision machinery, maiwei biology, dongxin shares, guobo electronics, yahuilong, strway and other companies successively issued institutional research announcements. the details are as follows:
Survey of Shanghai and Shenzhen Stock Exchange Institutions
| security code | security name | number of reception agencies | reception method | Date of Last Survey | |
|---|---|---|---|---|---|
| 002158 | hanzhong precision machine107 | site visit, online | 2024-02-23 | ||
| 688062 | Maiwei biological | 99 | target-specific research, roadshow activities, securities firm strategy meetings | 2024-02-01 | |
| 688110 | Dongxin shares | 87 | strategic meeting, roadshow event | 2024-02-29 | |
| 688375 | Guobo Electronics | 73 | Analyst Meeting | 2024-02-26 | |
| 688575 | Yafilong | 71 | Site visit, brokerage strategy meeting | 2024-02-26 | |
| 688213 | 65 | , roadshow Activity | 2024-02-26 | ||
| Data Source: Choice Data |
Disclaimer: This article is based on big data production, for reference only, does not constitute any investment advice, and operates at your own risk.
Ticker Name
Percentage Change
Inclusion Date
